Stocktoria
Sensus Healthcare, Inc. SRTS
Sensus Healthcare, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M | $9.6M | $27.3M | $26.4M | $20.6M | $14.8M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M | $5.2M | $17.6M | $16.9M | $13.8M | $9.8M |
| R&D expense | $7.8M | $4.2M | $3.7M | $3.5M | $3.4M | $4.2M | $6.4M | $6.3M | $5.5M | $1.8M |
| SG&A expense | $7.9M | $7.1M | $5.2M | — | — | — | — | — | — | — |
| Operating income | -$10.3M | $8.1M | -$382,000 | $14.8M | $4.1M | -$8.2M | -$2.0M | -$2.0M | -$3.7M | -$363,119 |
| Interest expense | — | -$932,000 | -$992,000 | -$380,000 | $2,000 | $14,000 | — | $156,685 | $68,881 | $21,867 |
| Income tax | -$1.9M | $2.4M | $167,000 | $3.7M | — | — | — | — | — | — |
| Net income | -$7.7M | $6.6M | $485,000 | $24.2M | $4.1M | -$6.8M | -$1.7M | -$2.0M | -$3.7M | -$346,448 |
| EPS (diluted) | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 | $-0.42 | — | — | — | — |
| Operating cash flow | $528,000 | -$831,000 | -$2.1M | -$1.4M | -$286,000 | -$434,000 | -$2.1M | -$8.6M | -$3.1M | -$851,024 |
| Free cash flow | $332,000 | -$1.1M | -$2.4M | -$1.6M | -$414,000 | -$793,000 | -$2.5M | -$9.4M | -$3.3M | -$1.1M |
| Cash & equivalents | $22.1M | $22.1M | $23.1M | $25.5M | $14.5M | $14.9M | $8.1M | $12.5M | $10.1M | $5.0M |
| Inventory | $14.6M | $10.1M | $11.9M | $3.5M | $1.8M | $4.4M | $3.0M | $1.6M | $1.2M | $1.3M |
| Total assets | $53.0M | $62.2M | $53.7M | $56.7M | $32.2M | $28.0M | $36.9M | $33.3M | $18.8M | $18.9M |
| Total liabilities | $4.9M | $6.3M | $4.9M | $8.7M | $6.2M | $6.5M | $8.9M | $6.8M | $7.2M | $3.7M |
| Shareholders' equity | $48.1M | $55.8M | $48.8M | $48.1M | $26.0M | $21.5M | $28.0M | $26.5M | $11.7M | $15.3M |
Growth · year-over-year · Revenue CAGR 7.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -34.3% | +71.3% | -45.2% | +64.7% | +182.4% | -64.9% | +3.2% | +28.4% | +39.0% | +44.2% |
| Net income growth | -216.1% | +1270.5% | -98.0% | +488.6% | — | — | — | — | — | — |
| EPS growth | -214.6% | +1266.7% | -97.9% | +484.0% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.